Bridger Management, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Bridger Management, LLC reported 27 stock positions worth $194.3 million. Its top holding was Eli Lilly (LLY) at 11.5% of the portfolio, followed by Uber Technologies (UBER, 11.3%) and Vertex Pharmaceuticals (VRTX, 9.9%). Compared with Q1 2024, it opened 2 new positions, sold out of 5, added to 2 and reduced 4. The biggest buy was a new position in Bausch + Lomb (BLCO) and the biggest sale an exit from Endeavor Group Hold Class A (EDR).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001166309
Portfolio Value
$194.3M (Q2 2024)
SEC Filing
0001166309-24-000016 ↗ filed Aug 14, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q1 2024: $221.8M Q1 2024 Q2 2024: $194.3M $194.3M Q2 2024 Q3 2024: $199.9M Q3 2024 Q4 2024: $186.1M Q4 2024 Q1 2025: $201.1M Q1 2025 Q2 2025: $169.5M Q2 2025 Q3 2025: $185.6M Q3 2025 Q4 2025: $155.5M Q4 2025 Q1 2026: $128.0M Q1 2026 Q2 2026: $150.1M Q2 2026

Holdings 27 stocks · $194.3M
LLY Eli Lilly & Co. 11.51% 24,712 $22.4M Reduce -12.0%
UBER Uber Technologies Inc. 11.27% 301,457 $21.9M No change
VRTX Vertex Pharmaceuticals Inc. 9.90% 41,050 $19.2M No change
MS Morgan Stanley 9.39% 187,714 $18.2M No change
TEVA Teva Pharmaceutical-SP ADR 8.20% 981,000 $15.9M Reduce -34.6%
PFE Pfizer Inc. 5.05% 350,500 $9.8M No change
TSM Taiwan Semiconductor-SP ADR 4.64% 51,826 $9.0M No change
ALNY Alnylam Pharmaceuticals Inc. 4.63% 37,022 $9.0M Reduce -30.0%
BBWI Bath & Body Works Inc. 4.46% 221,902 $8.7M Reduce -14.1%
BLCO Bausch + Lomb Corp. 3.78% 506,343 $7.4M New
MLCO Melco Resorts & Entert-ADR 3.78% 983,694 $7.3M Add +13.7%
CZR Caesars Entertainment Inc. 3.02% 147,625 $5.9M No change
XENE Xenon Pharmaceuticals Inc. 2.95% 146,800 $5.7M No change
GERN Geron Corp. 2.92% 1,338,084 $5.7M No change
SWTX Springworks Therapeutics Inc. 2.80% 144,526 $5.4M No change
DXCM Dexcom Inc. 1.69% 28,900 $3.3M No change
CPRX Catalyst Pharmaceuticals Inc. 1.47% 184,527 $2.9M No change
GOOGL Alphabet Inc. Class A 1.30% 13,900 $2.5M No change
QTRX Quanterix Corp. 1.05% 154,900 $2.0M No change
HLVX Hillevax Inc. 1.04% 140,100 $2.0M Add +29.5%
MSFT Microsoft Corp. 0.97% 4,230 $1.9M No change
TERN Terns Pharmaceuticals Inc. 0.86% 246,800 $1.7M No change
QURE Uniqure NV 0.84% 362,349 $1.6M No change
OSCR Oscar Health Inc. Class A 0.78% 95,700 $1.5M New
AMZN Amazon.com Inc. 0.72% 7,264 $1.4M No change
TOST Toast Inc. Class A 0.70% 52,692 $1.4M No change
NEXT Nextdecade Corp. 0.28% 67,837 $539K No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $8K (not counted above)
SecurityClassShares / PrincipalValueChange
SRZNW Surrozen Inc.-CW25 *W EXP 08/01/203 466,666$8KNo change

Total filed on the 13F, all lines: $194.3M.

Portfolio Sells Q1 2024 → Q2 2024
EDR Endeavor Group Hold Class A Sold out 0.00% −5.12
THC Tenet Healthcare Corp. Sold out 0.00% −4.15
CYTK Cytokinetics Inc. Sold out 0.00% −2.18
ATRC Atricure Inc. Sold out 0.00% −1.37
BBWI Bath & Body Works Inc. Reduce -14.1% 4.46% −1.37
TEVA Teva Pharmaceutical-SP ADR Reduce -34.6% 8.20% −1.34
SPOT Spotify Technology SA Sold out 0.00% −0.63
ALNY Alnylam Pharmaceuticals Inc. Reduce -30.0% 4.63% +1.06
LLY Eli Lilly & Co. Reduce -12.0% 11.51% +1.67

Portfolio Buys Q1 2024 → Q2 2024
BLCO Bausch + Lomb Corp. New 3.78% +3.78
MLCO Melco Resorts & Entert-ADR Add +13.7% 3.78% +0.96
OSCR Oscar Health Inc. Class A New 0.78% +0.78
HLVX Hillevax Inc. Add +29.5% 1.04% +0.23

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 23$150.1MMS, AMZN, TEVA, UNH, FLUT
Q1 2026 23$128.0MMS, AMZN, TEVA, FLUT, DXCM
Q4 2025 23$155.5MMS, AMZN, TEVA, NKE, ALC
Q3 2025 27$185.6MMS, AMZN, TEVA, NKE, UBER
Q2 2025 24$169.5MMS, UBER, AMZN, TEVA, PFE
Q1 2025 28$201.1MMS, VRTX, UBER, AMZN, PFE
Q4 2024 27$186.1MMS, UBER, VRTX, TEVA, PFE
Q3 2024 28$199.9MUBER, MS, VRTX, TEVA, ALNY
Q2 2024 27$194.3MLLY, UBER, VRTX, MS, TEVA
Q1 2024 30$221.8MUBER, LLY, TEVA, MS, VRTX